ARG Site A March Site B March Site A June Site B June Site A Oct Site B Nov
Tetracycline tet(39) 1 KT346360 14/34 (42%) 23/33 (70%) 23/32 (72%) 30/33 (91%) 22/32 (69%) 29/37 (79%)
Tetracycline 41 2477 Branch 26/34 (77%) 21/33 (64%) 27/32 (85%) 20/33 (61%) 18/32 (57%) 22/37 (60%)
Sulphonamide sul 2331 Branch 14/34 (42%) 20/33 (61%) 21/32 (66%) 29/33 (88%) 17/32 (54%) 18/37 (49%)
Aminoglycoside aadA1 1 X02340 13/34 (39%) 17/33 (52%) 19/32 (60%) 30/33 (91%) 14/32 (44%) 20/37 (55%)
Macrolide lnu(C) 1 AY928180 19/34 (56%) 16/33 (49%) 23/32 (72%) 19/33 (58%) 15/32 (47%) 19/37 (52%)
Macrolide lnu(A) 1 M14039 15/34 (45%) 17/33 (52%) 21/32 (66%) 19/33 (58%) 17/32 (54%) 17/37 (46%)
Polimixin Colistin pmrC 11/34 (33%) 19/33 (58%) 18/32 (57%) 27/33 (82%) 14/32 (44%) 17/37 (46%)
Polimixin Colistin bacA 12/34 (36%) 16/33 (49%) 15/32 (47%) 26/33 (79%) 17/32 (54%) 16/37 (44%)
Class A beta-lactamases pbp2 Ecoli 10/34 (30%) 17/33 (52%) 16/32 (50%) 26/33 (79%) 12/32 (38%) 17/37 (46%)
Sulfa Drugs mdtN 10/34 (30%) 17/33 (52%) 16/32 (50%) 25/33 (76%) 13/32 (41%) 17/37 (46%)
Aminoglycoside aph(3')-III 1 M26832 17/34 (50%) 14/33 (43%) 18/32 (57%) 16/33 (49%) 15/32 (47%) 15/37 (41%)
Polimixin Colistin pmrF 11/34 (33%) 16/33 (49%) 15/32 (47%) 24/33 (73%) 14/32 (44%) 15/37 (41%)
Aminoglycoside aadE 1 KF864551 15/34 (45%) 15/33 (46%) 19/32 (60%) 16/33 (49%) 14/32 (44%) 15/37 (41%)
Aminoglycoside aadD 1 AF181950 11/34 (33%) 11/33 (34%) 10/32 (32%) 10/33 (31%) 13/32 (41%) 11/37 (30%)